Search
for
Sort by
Research 511–540 of 1000+
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Novel drugs of United States Food and Drug Administration approved in 2024
- Development and Evaluation of a Novel Delivery System Containing Phytophospholipid Complex for Skin Aging
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- FORMULATION DEVELOPMENT AND STABILITY OF MORINGA OLEIFERA SEED OIL NANOEMULSION-BASED HAIR SERUM
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Increase in IL-15 levels in patients with alopecia areata
- Acupuncture improves anxiety and depression in patients with polycystic ovary syndrome: a systematic evaluation and meta-analysis
- Cross‐sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: A frequent finding of non‐scarring patch alopecia
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Evaluation of Quality of Life, Anxiety and Depression in Patients with Alopecia Areata: A Prospective Case-Control Study
- Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis
- The psychology of hair loss and its implications for patient care
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Food Habits, Daily Routine and Hair Loss — A Focused Review
- A cross-specialty expert opinion on the management of hair loss in gynaecological and endocrinological disorders in Indian patients
- Uveodermatological syndrome in dogs: A review of diagnosis, management, and ophthalmic patient needs
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- MicroRNAs in skin tissue engineering
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- A machine learning and network framework to discover new indications for small molecules